People living with inflammatory arthritis, including rheumatoid arthritis, psoriatic arthritis, and spondyloarthritis, experience symptoms that affect daily life, including pain and fatigue. Although new drugs have helped control inflammation, many people still report significant pain even when disease activity is low.

Traditional clinical measurements, such as swollen joint counts or CRP, are not always good at predicting future pain levels in individuals. One reason could be that they don’t capture other important parts of daily life, such as sleep, diet, or mental health. Data collected through smartphones can provide more frequent, real world insights and help fill this gap.

This edition of Tap into Research looks at a study that aimed to identify predictors of short-term pain relief in people with inflammatory arthritis who were prescribed a digital self-management app.

How were smartphones used in the study?

The study used data from the Mida Rheuma App, a certified medical device designed to support self-management. This smartphone app allows people to track symptoms and disease progression and provides educational content on nutrition, weight management, sleep, fatigue, and physical activity. Users can choose to contribute their data for research purposes.

What did the study find?

The study included 914 adults who used the app for 12 weeks. It explored which baseline factors predicted a clinically meaningful reduction in pain intensity at follow‑up. It found that:

• 232 people (25%) experienced a clinically meaningful reduction in pain after 12 weeks.
• Higher baseline pain was the strongest predictor of improvement. People starting with more severe pain were more likely to show a meaningful reduction and tended to have larger percentage improvements. Some of this reflects regression to the mean, but it also suggests that higher inflammatory pain may be more responsive to the app’s intervention.
• Higher baseline fatigue was associated with a lower chance of improvement. Severe fatigue appeared to limit the effectiveness of self management strategies.
• Better sleep quality independently improved the odds of improvement, regardless of baseline pain or diagnosis.
• Completing the daily tasks on the app regularly was associated with better outcomes.

Why does this matter?

The study highlights key predictors of short-term pain relief, showing that fatigue may be a major barrier to improvement, and better sleep improves pain outcomes. It also showed that having a meaningful reduction in pain was complex and influenced by many factors.

These findings would need external validation before informing clinical guidance. However, they suggest that future digital therapies may benefit from more targeted fatigue-focused and sleep-focused interventions.

Read the paper: Baseline pain, fatigue, and sleep quality predict 12-week pain improvement in inflammatory arthritis: retrospective real-world analysis of a digital health application cohort

Related